A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the long-term safety and efficacy of VI-0521
(phentermine/topiramate) compared to placebo in providing blood sugar control in Type 2
diabetic adults. Continuation of initial 6 month trial.